ID   PD41
AC   CVCL_C8A8
SY   PD41.84
DR   Wikidata; Q123033257
RX   Patent=US5314996;
RX   Patent=WO1993014775A1;
RX   PubMed=1705172;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11094.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human prostate mucin antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
RX   Patent=US5314996;
RA   Wright G.L. Jr.;
RT   "Isolated nucleotide sequences encoding an: antigen binding site of
RT   monoclonal antibody PD41; and antigen associated with prostate
RT   adenocarcinomas.";
RL   Patent number US5314996, 24-May-1994.
//
RX   Patent=WO1993014775A1;
RA   Wright G.L. Jr.;
RT   "Monoclonal antibody PD41 and antigen associated with prostate
RT   adenocarcinomas.";
RL   Patent number WO1993014775A1, 05-May-1993.
//
RX   PubMed=1705172;
RA   Beckett M.L., Lipford G.B., Haley C.L., Schellhammer P.F.,
RA   Wright G.L. Jr.;
RT   "Monoclonal antibody PD41 recognizes an antigen restricted to prostate
RT   adenocarcinomas.";
RL   Cancer Res. 51:1326-1333(1991).
//